Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of EUR 3.77 million. The enterprise value is 3.43 million.

Market Cap	3.77M
Enterprise Value	3.43M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	101.29M
Shares Outstanding	n/a
Shares Change (YoY)	-2.09%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.60%
Owned by Institutions (%)	n/a
Float	92.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.21
PB Ratio	4.76
P/TBV Ratio	5.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.45
EV / Sales	2.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.73

Financial Position

The company has a current ratio of 17.92

Current Ratio	17.92
Quick Ratio	15.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.10% and return on invested capital (ROIC) is -26.61%.

Return on Equity (ROE)	-86.10%
Return on Assets (ROA)	-23.12%
Return on Invested Capital (ROIC)	-26.61%
Return on Capital Employed (ROCE)	-62.26%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.88
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.50%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	45.69
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Avricore Health had revenue of EUR 1.18 million and -996,272 in losses. Loss per share was -0.01.

Revenue	1.18M
Gross Profit	511,256
Operating Income	-492,720
Pretax Income	-996,272
Net Income	-996,272
EBITDA	-353,691
EBIT	-492,720
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 331,494 in cash and n/a in debt, giving a net cash position of 331,494.

Cash & Cash Equivalents	331,494
Total Debt	n/a
Net Cash	331,494
Net Cash Per Share	n/a
Equity (Book Value)	791,426
Book Value Per Share	0.01
Working Capital	371,594

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -89,769 and capital expenditures -54,878, giving a free cash flow of -144,647.

Operating Cash Flow	-89,769
Capital Expenditures	-54,878
Free Cash Flow	-144,647
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 43.48%, with operating and profit margins of -41.91% and -84.73%.

Gross Margin	43.48%
Operating Margin	-41.91%
Pretax Margin	-84.73%
Profit Margin	-84.73%
EBITDA Margin	-30.08%
EBIT Margin	-41.91%
FCF Margin	n/a

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.09%
Shareholder Yield	2.09%
Earnings Yield	-26.44%
FCF Yield	-3.84%

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.25

Scores

Avricore Health has an Altman Z-Score of 89.42 and a Piotroski F-Score of 3.

Altman Z-Score	89.42
Piotroski F-Score	3